A pharmaceutical technopark is planned to be established in the Baikal region

Print 09 January 2018
GMP News

A meeting of Scientific Coordination Council under the Governor of the Irkutsk region was held in the Government of the Irkutsk region. The meeting was attended by Sergey Levchenko, the head of the region, and discussed the establishment of an innovative chemical and pharmaceutical technopark.

Andrey Ivanov, the Director of A.E. Favorsky Institute of Chemistry, a federal state budgetary institution of the Siberian Branch of the Russian Academy of Sciences, spoke about the establishment of an innovative chemical and pharmaceutical technopark in the Irkutsk region. This project provides for establishing a chemical and pharmaceutical technopark in the Baikal region to develop the medicinal products and medical devices and conduct the relevant preclinical studies in accordance with the international standards.

The project takes into account the strategic location of the region at the junction of traditional Western and traditional Oriental medicines and is aimed at creating new innovative drugs based on synthetic capacity of the major chemical research institute, and introducing the medicines made from natural raw materials of Siberia, the Russian Far East and adjacent regions of South-East Asia, studying their properties and manufacturing the small amounts of medicinal products, said Andrey Ivanov.

This means that the plans provide for the establishment of a full-fledged medical cluster that will include all stages of introducing the medicines into the world practice – from synthesis and extraction to clinical trials and production.

Source

Return